Full name
CITIFARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
47 - Retail trade
68 - Real estate activities
70 - Head office activities and management consultancy
73 - Advertising, market research and public relations
74 - Other professional, scientific and technical activities
82 - Office administrative support activities and other business support services
85 - Education
86 - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,1 | 0 | 0,1 | 297,3 |
EBITDA | -0 | 0 | 0 | -20,2 |
Short time liabilities | 0,2 | 0,2 | 0,2 | 28,6 |
Income tax | 0 | |||
Equity capital | 0,1 | 0,1 | 0,2 | 78,6 |
Operating profit (EBIT) | -0,1 | 0 | 0 | -33,6 |
Assets | 0,3 | 0,3 | 0,4 | 45,3 |
Net profit (loss) | -0,1 | 0 | 0,1 | 234,3 |
Cash | 0,1 | 0,1 | 0,2 | 170,7 |
Net income from sale | 1,8 | 2,1 | 2,7 | 27,3 |
Liabilities and provisions for liabilities | 0,2 | 0,2 | 0,2 | 28,6 |
Working assets | 0,2 | 0,2 | 0,4 | 74,2 |
Depreciation | 0 | 0 | 0 | -0 |
Basic operational activity income | 16,4 | |||
% | % | % | p.p. | |
Profitability of capital | -85,2 | 23,5 | 44 | 20,5 |
Equity capital to total assets | 27,5 | 33,3 | 40,9 | 7,6 |
Gross profit margin | -3,4 | 1,1 | 3,3 | 2,2 |
EBITDA Margin | -2,6 | 1,8 | 1,1 | -0,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 38 | 33 | 33 | 0 |
Current financial liquidity indicator | 1.0234084129333496 | 1.0659856796264648 | 1.4436379671096802 | 0,3 |
Net dept to EBITDA | 1.7040517330169678 | -2.0237038135528564 | -6.868631839752197 | -4,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane